Inactive Instrument
Canntab Therapeutics Limited Stock
Stocks
CTABF
CA1377991023
Pharmaceuticals
OTC Markets Traded| 1 day | -99.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 2020-05-14 | |
Frank Candido
IRC | Investor Relations Contact | 61 | 2018-08-31 |
Eric Malinski
SAM | Sales & Marketing | - | 2018-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-02-05 | Option | Director | 100,000 | 0.2570% | ||
| 24-02-05 | Option | Director | 100,000 | 0.2570% | ||
| 22-02-21 | Sell | Chief Executive Officer | 400,000 | 1.0717% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | -.--% | - | - | 38 | |
| +1.27% | -1.15% | -14.02% | -8.59% | 12.44B | |
| +0.61% | -1.52% | -35.52% | -59.61% | 4.67B | |
| +1.50% | +1.63% | -11.97% | -13.86% | 4.29B | |
| +2.33% | -0.58% | +8.87% | -40.25% | 3.69B | |
| +2.98% | +1.48% | +14.90% | -14.61% | 3.68B | |
| +1.22% | -13.98% | -14.70% | -22.66% | 3.01B | |
| +2.80% | -1.95% | -13.10% | -6.27% | 2.91B | |
| +3.15% | -1.57% | -7.27% | -26.86% | 2.27B | |
| +3.04% | -0.25% | -11.91% | +24.35% | 1.61B | |
| Average | -8.01% | +0.49% | -9.41% | -18.71% | 4.28B | |
| Weighted average by Cap. | +1.78% | +0.97% | -10.95% | -19.58% |
Employees
-
Sector
Pharmaceuticals
